Capital A Wealth Management »

Halozyme Therapeutics shares owned by Capital A Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Capital A Wealth Management from 13F filings

Historical chart of Capital A Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Capital A Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Capital A Wealth Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $924 25 36.96
2024-12-31 $48 1 48.00